Axio Biosolutions
3 employees
Biomaterials
Series B · $20.5M
Open positions (3)
Company details
Team Size3
IndustryBiomaterials
Funding
Total raised
$20.5M
Last stage
Series B
Investors
Accel
Total raised
$20.5M
Last stage
Series B
Investors
Leo Mavely
Co-founded Axio Biosolutions in 2008 after incubation at NirmaLabs, Ahmedabad. Bioengineering undergraduate who led the development of Axiostat, India's first USFDA-cleared wound care/hemostat product.
LinkedInAshish Pandya
Co-founded Axio Biosolutions alongside Leo Mavely; worked on developing hemostatic wound care solutions at NirmaLabs incubator.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.